Mackenzie Financial
AUPH icon

Mackenzie Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

Mackenzie Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,719
Closed -$118K – 1676
2025
Q3 		$118K Hold
10,719
– – ﹤0.01% 1617
2025
Q2 		$90.8K Hold
10,719
– – ﹤0.01% 1623
2025
Q1 		$86.2K Buy
+10,719
New +$86.8K ﹤0.01% 1596
2021
Q3 		– Sell
-27,877
Closed -$361K – 1436
2021
Q2 		$361K Buy
27,877
+574
+2% +$7.31K ﹤0.01% 1038
2021
Q1 		$355K Buy
27,303
+15,046
+123% +$218K ﹤0.01% 1000
2020
Q4 		$169K Buy
12,257
+407
+3% +$5.92K ﹤0.01% 1001
2020
Q3 		$175K Buy
+11,850
New +$172K ﹤0.01% 935

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return